[go: up one dir, main page]

BG62120B1 - Фармацевтични състави за ректално приложение наалкилсулфонамиди - агонисти на 5-нт1 - Google Patents

Фармацевтични състави за ректално приложение наалкилсулфонамиди - агонисти на 5-нт1 Download PDF

Info

Publication number
BG62120B1
BG62120B1 BG99167A BG9916794A BG62120B1 BG 62120 B1 BG62120 B1 BG 62120B1 BG 99167 A BG99167 A BG 99167A BG 9916794 A BG9916794 A BG 9916794A BG 62120 B1 BG62120 B1 BG 62120B1
Authority
BG
Bulgaria
Prior art keywords
pharmaceutical composition
active ingredient
composition according
methyl
pharmaceutically acceptable
Prior art date
Application number
BG99167A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG99167A (bg
Inventor
Nadine Merlet
Isabelle Richard
Isabelle Thielemans
Original Assignee
Laboratoires Glaxo Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Glaxo Sa filed Critical Laboratoires Glaxo Sa
Publication of BG99167A publication Critical patent/BG99167A/bg
Publication of BG62120B1 publication Critical patent/BG62120B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
BG99167A 1992-05-07 1994-11-07 Фармацевтични състави за ректално приложение наалкилсулфонамиди - агонисти на 5-нт1 BG62120B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929209882A GB9209882D0 (en) 1992-05-07 1992-05-07 Compositions
PCT/EP1993/001077 WO1993021916A1 (en) 1992-05-07 1993-05-03 Pharmaceutical compositions of alkylsulphonamides 5ht1 agonists for rectal administration

Publications (2)

Publication Number Publication Date
BG99167A BG99167A (bg) 1995-06-30
BG62120B1 true BG62120B1 (bg) 1999-03-31

Family

ID=10715158

Family Applications (1)

Application Number Title Priority Date Filing Date
BG99167A BG62120B1 (bg) 1992-05-07 1994-11-07 Фармацевтични състави за ректално приложение наалкилсулфонамиди - агонисти на 5-нт1

Country Status (33)

Country Link
US (1) US5705506A (it)
EP (1) EP0639072B1 (it)
JP (1) JPH07506570A (it)
KR (1) KR100253111B1 (it)
AT (1) ATE163850T1 (it)
AU (1) AU670083B2 (it)
BE (1) BE1007024A5 (it)
BG (1) BG62120B1 (it)
BR (1) BR1100108A (it)
CA (1) CA2135179C (it)
CH (1) CH685920A5 (it)
CY (1) CY2039B1 (it)
CZ (1) CZ283512B6 (it)
DE (1) DE69317418T2 (it)
ES (1) ES2113533T3 (it)
FR (1) FR2690847B1 (it)
GB (2) GB9209882D0 (it)
GR (1) GR3026584T3 (it)
HK (1) HK95697A (it)
HU (2) HU227338B1 (it)
IE (1) IE75203B1 (it)
IL (1) IL105468A (it)
IT (1) IT1261471B (it)
NO (1) NO306700B1 (it)
NZ (1) NZ252132A (it)
OA (1) OA10109A (it)
RO (1) RO112993B1 (it)
RU (1) RU2118527C1 (it)
SG (1) SG46649A1 (it)
TW (1) TW231970B (it)
UA (1) UA37206C2 (it)
WO (1) WO1993021916A1 (it)
ZA (1) ZA933178B (it)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2434297A (en) * 1996-05-23 1997-12-09 Alcon Laboratories, Inc. The use of 5-ht1b/1d agonists to treat ocular pain
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
TR200002771T2 (tr) * 1998-03-26 2001-02-21 Fujisawa Pharmaceutical Co.,Ltd. Devamlı salımı olan preparatlar
AU3731400A (en) * 1999-03-05 2000-09-21 Trustees Of University Technology Corporation, The Methods and compositions useful in inhibiting apoptosis
AR056690A1 (es) * 2005-10-14 2007-10-17 Athersys Inc Derivados de indol como inhibidores de indol como inhibidores del receptor 3 de histamina para el tartamiento de trastornos del sueno y cognitivos obesidad y otros trastornos de snc
SI2124556T1 (sl) 2006-10-09 2015-01-30 Charleston Laboratories, Inc. Farmacevtske sestave
JP5714910B2 (ja) 2008-01-09 2015-05-07 チャールストン ラボラトリーズ，インコーポレイテッド 薬学的組成物
WO2011006012A1 (en) 2009-07-08 2011-01-13 Charleston Laboratories Inc. Pharmaceutical compositions
US9186359B2 (en) 2010-10-15 2015-11-17 Contera Pharma Aps Combinations of serotonin receptor agonists for treatment of movement disorders
SG11201406690SA (en) 2012-04-18 2014-11-27 Contera Pharma Aps Orally available pharmaceutical formulation suitable for improved management of movement disorders
WO2017152130A1 (en) 2016-03-04 2017-09-08 Charleston Laboratories, Inc. Pharmaceutical compositions
WO2018011181A1 (en) 2016-07-11 2018-01-18 Contera Pharma Aps Pulsatile drug delivery system for treating morning akinesia

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2082175B (en) * 1980-08-12 1984-05-02 Glaxo Group Ltd Heterocyclic compounds
GB2083463B (en) * 1980-08-12 1984-05-10 Glaxo Group Ltd Heterocyclic compounds
ZW19381A1 (en) * 1980-08-12 1983-03-09 Glaxo Group Ltd Heterocyclic compounds
IT1170387B (it) * 1982-06-07 1987-06-03 Glaxo Group Ltd Composti eterociclici, procedimento per prepararli e composizioni farmaceutiche che li contengono
GB8332435D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Chemical compounds
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
FR2574077A1 (fr) * 1984-12-04 1986-06-06 Glaxo Group Ltd Derives d'indoles, leur preparation et les compositions pharmaceutiques les contenant
GB8431426D0 (en) * 1984-12-13 1985-01-23 Glaxo Group Ltd Chemical compounds
DE3678805D1 (de) * 1985-11-08 1991-05-23 Glaxo Group Ltd Indolderivate.
KR0131327B1 (en) * 1987-08-13 1998-04-17 Glaxo Group Ltd Indole derivatives
MC2210A1 (fr) * 1990-06-07 1992-11-26 Wellcome Found Composes heterocycliques therapeutiques,leur utilisation et procede pour les preparer

Also Published As

Publication number Publication date
OA10109A (en) 1996-12-18
EP0639072A1 (en) 1995-02-22
ITRM930286A0 (it) 1993-05-06
NO944214L (no) 1994-11-07
DE69317418D1 (de) 1998-04-16
GB9209882D0 (en) 1992-06-24
NO944214D0 (no) 1994-11-04
RU2118527C1 (ru) 1998-09-10
NO306700B1 (no) 1999-12-13
BR1100108A (pt) 1999-12-07
US5705506A (en) 1998-01-06
GR3026584T3 (en) 1998-07-31
HUT71418A (en) 1995-11-28
ATE163850T1 (de) 1998-03-15
SG46649A1 (en) 1998-02-20
BG99167A (bg) 1995-06-30
CZ283512B6 (cs) 1998-04-15
UA37206C2 (uk) 2001-05-15
DE69317418T2 (de) 1998-07-30
KR100253111B1 (en) 2000-07-01
BE1007024A5 (fr) 1995-02-21
ES2113533T3 (es) 1998-05-01
TW231970B (it) 1994-10-11
IT1261471B (it) 1996-05-23
IL105468A (en) 1998-09-24
GB2266665B (en) 1996-05-22
ZA933178B (en) 1994-01-10
WO1993021916A1 (en) 1993-11-11
EP0639072B1 (en) 1998-03-11
GB2266665A (en) 1993-11-10
CA2135179C (en) 2000-12-05
HU227338B1 (en) 2011-04-28
AU670083B2 (en) 1996-07-04
AU4064093A (en) 1993-11-29
CZ272394A3 (en) 1995-10-18
ITRM930286A1 (it) 1994-11-06
CH685920A5 (fr) 1995-11-15
NZ252132A (en) 1996-09-25
GB9309209D0 (en) 1993-06-16
FR2690847B1 (fr) 1995-06-09
JPH07506570A (ja) 1995-07-20
HK95697A (en) 1997-08-08
IE75203B1 (en) 1997-08-27
CY2039B1 (en) 1998-04-30
IL105468A0 (en) 1993-08-18
FR2690847A1 (fr) 1993-11-12
RO112993B1 (ro) 1998-03-30
IE930339A1 (en) 1993-11-17
HU211638A9 (en) 1995-12-28
CA2135179A1 (en) 1993-11-11

Similar Documents

Publication Publication Date Title
JP2000507544A (ja) 痛みの治療方法
BG62120B1 (bg) Фармацевтични състави за ректално приложение наалкилсулфонамиди - агонисти на 5-нт1
RU2308268C2 (ru) Производные арил- или гетероарилазолилкарбинолов для лечения недержания мочи
EA001325B1 (ru) Способы лечения и профилактики интерстициального цистита
JP2965703B2 (ja) 直腸用組成物
AU3810100A (en) Stable pharmaceutical application form for paroxetin anhydrate
KR920703593A (ko) 이미다조퀴녹살린 화합물, 이의 제조방법 및 용도
HK1069530A (en) Aryl (or heteroaryl) azolylcarbynol derivatives for the treatment of urinary incontinence
HK1035143B (en) Pharmaceutical combinations containing tramadol for the production of a medicament for the treatment of migraine or migrainoid headaches